| Unique ID issued by UMIN | UMIN000056498 |
|---|---|
| Receipt number | R000064564 |
| Scientific Title | A multicenter Study of the Current Status of Maze Surgery and the Optimal Line of Ablation for Atrial Fibrillation in Japan |
| Date of disclosure of the study information | 2025/01/06 |
| Last modified on | 2025/01/05 16:14:38 |
A multicenter Study of the Current Status of Maze Surgery and the Optimal Line of Ablation for Atrial Fibrillation in Japan
A multicenter Study of the Current Status of Maze Surgery and the Optimal Line of Ablation for Atrial Fibrillation in Japan
A multicenter Study of the Current Status of Maze Surgery and the Optimal Line of Ablation for Atrial Fibrillation in Japan
A multicenter Study of the Current Status of Maze Surgery and the Optimal Line of Ablation for Atrial Fibrillation in Japan
| Japan |
Patients who underwent surgical atrial fibrillation surgery (Maze procedure) in 2002 at our institution and at the institutions participating in this study.
| Cardiovascular surgery |
Others
NO
The purpose of this multicenter study is to investigate the current status of Maze surgery in Japan and to clarify the background and indications of patients undergoing Maze surgery, the details of Maze surgery procedures (especially the cautery line) performed, and the results of these procedures. Subsequently, the study will provide information that will enable surgeons to clearly identify the indications for Maze surgery by identifying the group of patients who can be defibrillated at a high rate.
Safety,Efficacy
To identify risk factors for atrial fibrillation recurrence based on the rate of atrial fibrillation avoidance in the first postoperative year.
To identify risk factors for the development of postoperative complications such as the presence or absence of stroke, pacemaker implantation rate, and the development of refractory postoperative supraventricular arrhythmias.
Observational
| Not applicable |
| Not applicable |
Male and Female
Patients who underwent maze surgery for atrial fibrillation at each institution in 2022.
none
1000
| 1st name | Yamaguchi |
| Middle name | |
| Last name | Hiroki |
Showa-university Koto-toyosu Hospital
Department of cardiovascular surgery
135-8577
Toyosu 5-1-38, Koto-ku, Tokyo, Japan
03-6204-6000
hyamaguchi@med.showa-u.ac.jp
| 1st name | Nakamura |
| Middle name | |
| Last name | Hiromasa |
Showa-university Koto-toyosu Hospital
Department of cardiovascular suregry
135-8577
Toyosu 5-1-38, Koto-ku, Tokyo, Japan
09082843959
kinakamurah@gmail.com
Showa-university Koto-toyosu Hospital, Department of cardiovascular surgery
Medtronic co.
Profit organization
Showa University Center for Supervision and Research Promotion
3F, Building 1, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo
03-3784-8000
surac1@ofc.showa-u.ac.jp
NO
| 2025 | Year | 01 | Month | 06 | Day |
Unpublished
Preinitiation
| 2024 | Year | 10 | Month | 01 | Day |
| 2024 | Year | 12 | Month | 25 | Day |
| 2025 | Year | 12 | Month | 31 | Day |
To determine the details of maze surgeries performed at each institution in 2022. The questionnaire will focus on the background and indications of patients who underwent maze surgery at each institution, details of the maze surgery procedure performed, and especially the ablation line. Information will also be collected on the presence or absence of defibrillation, postoperative complications of supraventricular arrhythmias, and occurrence of stroke.
| 2024 | Year | 12 | Month | 19 | Day |
| 2025 | Year | 01 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064564